Kidney transplant outcomes in patients with antibodies to human neutrophil antigen 3a.

Emma Cannon,Karen Stevenson,Ann-Margaret Little, David McKenzie,Catherine Hastie,Anthony Calvert,Anthony Poles,Richard Battle,Sylvia McConnell,Paul Phelan,David Turner

Transplant immunology（2023）

引用 0|浏览7

暂无评分

摘要

The predicted rate of HNA-3a antibodies amongst patients awaiting kidney transplant in the UK is <1%. However, with increasing evidence to support a role for HNA-3a antibodies in the development of ABMR there may be value in screening at risk groups to allow for augmented immunosuppression to be considered at the time of kidney transplant.

查看译文

关键词

human neutrophil antigen,kidney transplant outcomes,antibodies

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要